Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
Cien Saude Colet ; 26(1): 297-307, 2021 Jan.
Article in Portuguese, English | MEDLINE | ID: mdl-33533851

ABSTRACT

The objective of this study was to analyze the temporal trend of the incidence coefficients of HIV-AIDS infection via a retrospective ecological study and segmented regression in individuals older than 13 year reported at SINAN between 1980 and 2016. Of the 14,204 reported cases, 70.9% were male and 39.5% were white. The AIDS criterion presented growing incidence from 1986 to 1996 with Annual Percentual Change (APC) of 108.5% per year between 1983 and 1989 (CI: 90.3 - 128.4), between 1989 and 1998 the APC was 13.2% (CI: 8.2 - 18.3) and APC reduction in the period from 1998 to 2016, -6.2% (CI: -7.4 - -4.9). High coefficients of the death criteria between 1988 and 2002 (4.7/100,000 inhabitants), with a noticeable decrease after 1995. The growth of the HIV+ criteria from 2000 onward was observed, reaching 30.2 cases per 100,000 inhabitants in 2016. Although incidence rates still remain high in the municipality, these trends are consistent with the positive impact of early detection policies and access to clinical and therapeutic follow-up of individuals with HIV and AIDS in Campinas.


O estudo teve por objetivo analisar a tendência temporal dos coeficientes de incidência da infecção por HIV-aids por meio de estudo ecológico retrospectivo e regressão segmentada em maiores de 13 anos notificados no SINAN entre os anos de 1980 e 2016. Dos 14.204 casos notificados, 70,9% eram do sexo masculino e 39,5% brancos. Nota-se aumento da incidência do critério aids de 1986 a 1996 com variação anual percentual (APC) de 108,5% ao ano entre 1983 a 1989 (IC: 90,3 - 128,4), entre os anos de 1989 e 1998 a APC foi de 13,2% (IC: 8,2 - 18,3) e redução da APC no período de 1998 a 2016, -6,2% (IC: -7,4 - -4,9). Altos coeficientes do critério óbito entre os anos 1988 a 2002 (4,7/100.00 hab.) com queda acentuada após 1995. Observa-se crescimento do critério HIV+ a partir do ano 2000, chegando a 30,2 por 100 mil habitantes em 2016. Embora as taxas de incidência ainda permaneçam altas no município, estas tendências são compatíveis com o impacto positivo das políticas de detecção precoce e acesso ao seguimento clínico e terapêutico dos indivíduos com HIV e aids na cidade.


Subject(s)
Acquired Immunodeficiency Syndrome , HIV Infections , Acquired Immunodeficiency Syndrome/diagnosis , Acquired Immunodeficiency Syndrome/epidemiology , Brazil/epidemiology , Cities , Female , HIV Infections/diagnosis , HIV Infections/epidemiology , Humans , Incidence , Male , Retrospective Studies
2.
Ciênc. Saúde Colet ; 26(1): 297-307, jan. 2021. tab, graf
Article in English, Portuguese | LILACS | ID: biblio-1153768

ABSTRACT

Resumo O estudo teve por objetivo analisar a tendência temporal dos coeficientes de incidência da infecção por HIV-aids por meio de estudo ecológico retrospectivo e regressão segmentada em maiores de 13 anos notificados no SINAN entre os anos de 1980 e 2016. Dos 14.204 casos notificados, 70,9% eram do sexo masculino e 39,5% brancos. Nota-se aumento da incidência do critério aids de 1986 a 1996 com variação anual percentual (APC) de 108,5% ao ano entre 1983 a 1989 (IC: 90,3 - 128,4), entre os anos de 1989 e 1998 a APC foi de 13,2% (IC: 8,2 - 18,3) e redução da APC no período de 1998 a 2016, -6,2% (IC: -7,4 - -4,9). Altos coeficientes do critério óbito entre os anos 1988 a 2002 (4,7/100.00 hab.) com queda acentuada após 1995. Observa-se crescimento do critério HIV+ a partir do ano 2000, chegando a 30,2 por 100 mil habitantes em 2016. Embora as taxas de incidência ainda permaneçam altas no município, estas tendências são compatíveis com o impacto positivo das políticas de detecção precoce e acesso ao seguimento clínico e terapêutico dos indivíduos com HIV e aids na cidade.


Abstract The objective of this study was to analyze the temporal trend of the incidence coefficients of HIV-AIDS infection via a retrospective ecological study and segmented regression in individuals older than 13 year reported at SINAN between 1980 and 2016. Of the 14,204 reported cases, 70.9% were male and 39.5% were white. The AIDS criterion presented growing incidence from 1986 to 1996 with Annual Percentual Change (APC) of 108.5% per year between 1983 and 1989 (CI: 90.3 - 128.4), between 1989 and 1998 the APC was 13.2% (CI: 8.2 - 18.3) and APC reduction in the period from 1998 to 2016, -6.2% (CI: -7.4 - -4.9). High coefficients of the death criteria between 1988 and 2002 (4.7/100,000 inhabitants), with a noticeable decrease after 1995. The growth of the HIV+ criteria from 2000 onward was observed, reaching 30.2 cases per 100,000 inhabitants in 2016. Although incidence rates still remain high in the municipality, these trends are consistent with the positive impact of early detection policies and access to clinical and therapeutic follow-up of individuals with HIV and AIDS in Campinas.


Subject(s)
Humans , Male , Female , HIV Infections/diagnosis , HIV Infections/epidemiology , Acquired Immunodeficiency Syndrome/diagnosis , Acquired Immunodeficiency Syndrome/epidemiology , Brazil/epidemiology , Incidence , Retrospective Studies , Cities
3.
AIDS Res Hum Retroviruses ; 31(12): 1219-24, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25826640

ABSTRACT

Transmitted drug resistance mutations (TDRM) have been a constant threat to treatment efficacy. We evaluated TDRM in plasma RNA of 217 antiretroviral therapy-naive patients from sites in the São Paulo metropolitan area, collected from 2012 to 2014. The partial HIV-1 polymerase region was sequenced using Big Dye terminators at an ABI 3130 Genetic Analyzer. TDRM was defined according to the Stanford database calibrated population resistance (CPR v.6.0), but other drug resistance mutations (DRM) considered at the IAS list (IAS, 2014) and at the Stanford HIV Database Genotyping Resistance Interpretation (GRI-HIVdb) were also described. Out of 78% (170/217) of patients with information on the time of diagnosis, most (83%, 141/170) had been recently diagnosed, with the first positive HIV serology at a median of 58 days (IQR 18-184). Subtype B predominated (70%), followed by subtype F (10%), BF (7.5%), C (7.5%), and BC (5%). TDRMs were observed in 9.2% (20/217, CI 95% 5.9% to 13.6%), mostly (5.2%) to nonnucleoside reverse transcriptase inhibitor (NNRTI) antiretroviral class. Among children and adolescents, only a single patient showed TDRMs. Additional non-CPR mutations were observed: 11.5% (25/217) according to IAS or 4.6% (10/217) according to GRI-HIVdb. Overall, 23.5% (51/217) of the cases had one or more DRM identified. TDRM prevalence differed significantly among some sites. These trends deserve continuous and systematic surveillance, especially with the new policies of treatment as prevention being implemented in the country.


Subject(s)
Disease Transmission, Infectious , Drug Resistance, Viral , HIV Infections/transmission , HIV Infections/virology , HIV-1/drug effects , Adolescent , Adult , Aged , Aged, 80 and over , Brazil , Child , Child, Preschool , Female , Genotype , HIV-1/enzymology , HIV-1/genetics , HIV-1/isolation & purification , Humans , Infant , Infant, Newborn , Male , Middle Aged , Sequence Analysis, DNA , Young Adult , pol Gene Products, Human Immunodeficiency Virus/genetics
4.
Adv Virol ; 2013: 878237, 2013.
Article in English | MEDLINE | ID: mdl-23401688

ABSTRACT

Human immunodeficiency virus type 1 (HIV-1) transmitted drug resistance (TDR) is an important public health issue. In Brazil, low to intermediate resistance levels have been described. We assessed 225 HIV-1 infected, antiretroviral naïve individuals, from HIV Reference Centers at two major metropolitan areas of Sao Paulo (Sao Paulo and Campinas), the state that concentrates most of the Brazilian Aids cases. TDR was analyzed by Stanford Calibrated Population Resistance criteria (CPR), and mutations were observed in 17 individuals (7.6%, 95% CI: 4.5%-11.9%). Seventy-six percent of genomes (13/17) with TDR carried a nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance mutation, mostly K103N/S (9/13, 69%), potentially compromising the preferential first-line therapy suggested by the Brazilian HIV Treatment Guideline that recommends efavirenz-based combinations. Moreover, 6/17 (35%) had multiple mutations associated with resistance to one or more classes. HIV-1 B was the prevalent subtype (80%); other subtypes include HIV-1 F and C, mosaics BC, BF, and single cases of subtype A1 and CRF02_AG. The HIV Reference Center of Campinas presented more cases with TDR, with a significant association of TDR with clade B infection (P < 0.05).

SELECTION OF CITATIONS
SEARCH DETAIL
...